Replies to post #25060 on Ayala Pharmaceuticals Inc (ADXS)

[lorema]

Yep,
-- Daniel J. O’Connor, chief executive officer, president and board member of Advaxis, Inc. (NASDAQ: ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of a proprietary Lm-based antigen delivery system, announced his resignation from the company and its board of directors today.